MedTrace Logo

Brillant Blue Versus Indocyanine Green for Macular Hole Surgery

NCT00757471 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-01-26

No results posted yet for this study

Summary

Macular Hole Surgery with two different Dyes

Conditions

  • Idiopathic Macular Holes

Interventions

PROCEDURE

Brillant Blue

Membrane Peeling with Brillant Blue

PROCEDURE

Indocyanine Green

Membrane Peeling with indocyanine Green

Sponsors & Collaborators

  • The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery

    lead OTHER

Principal Investigators

  • Katharina Kreppler, MD · The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery

  • Christiane I Falkner-Radler, MD · The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00757471 on ClinicalTrials.gov